Cargando…

Blocking FGFR4 exerts distinct anti‐tumorigenic effects in esophageal squamous cell carcinoma

BACKGROUND: The FGFR family can be activated by FGFs and plays important roles in regulating cell growth, differentiation, migration, and angiogenesis. Recent studies have suggested that FGFR4 could regulate several processes, including tumor progression. Esophageal squamous cell carcinoma (ESCC) is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xin, Zhongwei, Song, Xuemin, Jiang, Bin, Gongsun, Xin, Song, Liang, Qin, Qiming, Wang, Qiang, Shi, Mo, Liu, Xiangyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6275831/ https://www.ncbi.nlm.nih.gov/pubmed/30267473 http://dx.doi.org/10.1111/1759-7714.12883

Ejemplares similares

Inhibition of MUC1‐C regulates metabolism by AKT pathway in esophageal squamous cell carcinoma
por: GongSun, Xin, et al.
Publicado: (2018)

Inhibition of MUC1-C entering nuclear suppresses MYC expression and attenuates malignant growth in esophageal squamous cell carcinoma
por: Xin, Zhongwei, et al.
Publicado: (2018)

DNAJB6 Promotes Ferroptosis in Esophageal Squamous Cell Carcinoma
por: Jiang, Bin, et al.
Publicado: (2019)

CEP55 promotes the proliferation, migration and invasion of esophageal squamous cell carcinoma via the PI3K/Akt pathway
por: Jia, Yang, et al.
Publicado: (2018)

Overexpression of Suprabasin is Associated with Proliferation and Tumorigenicity of Esophageal Squamous Cell Carcinoma
por: Zhu, Jinrong, et al.
Publicado: (2016)

miR-671-5p Blocks The Progression Of Human Esophageal Squamous Cell Carcinoma By Suppressing FGFR2
por: Li, Xiaoyan, et al.
Publicado: (2019)

Prognostic implications of FGFR1 and MYC status in esophageal squamous cell carcinoma
por: Kwon, Dohee, et al.
Publicado: (2016)

MicroRNA-1 inhibits tumorigenicity of esophageal squamous cell carcinoma and enhances sensitivity to gefitinib
por: Yu, Qianqian, et al.
Publicado: (2018)

Deguelin, a Novel Anti-Tumorigenic Agent in Human Esophageal Squamous Cell Carcinoma
por: Baba, Yuh, et al.
Publicado: (2017)

Human papillomavirus type 18 oncoproteins exert their oncogenicity in esophageal and tongue squamous cell carcinoma cell lines distinctly
por: Boon, Siaw Shi, et al.
Publicado: (2019)

FGFR2 Promotes Breast Tumorigenicity through Maintenance of Breast Tumor-Initiating Cells
por: Kim, Sungeun, et al.
Publicado: (2013)

Gene amplification of EGFR, HER2, FGFR2 and MET in esophageal squamous cell carcinoma
por: KATO, HIROAKI, et al.
Publicado: (2013)

Overexpression of PRR11 promotes tumorigenic capability and is associated with progression in esophageal squamous cell carcinoma
por: Zhou, Li, et al.
Publicado: (2019)

RHCG Suppresses Tumorigenicity and Metastasis in Esophageal Squamous Cell Carcinoma via Inhibiting NF-κB Signaling and MMP1 Expression
por: Ming, Xiao-Yan, et al.
Publicado: (2018)

Correction to: Human papillomavirus type 18 oncoproteins exert their oncogenicity in esophageal and tongue squamous cell carcinoma cell lines distinctly
por: Boon, Siaw Shi, et al.
Publicado: (2019)

Eosinophils Exert Antitumorigenic Effects in the Development of Esophageal Squamous Cell Carcinoma
por: Jacobse, Justin, et al.
Publicado: (2023)

The FGFR Family Inhibitor AZD4547 Exerts an Antitumor Effect in Ovarian Cancer Cells
por: Na, Yu Ran, et al.
Publicado: (2021)

FGFR1 Amplification Is Often Homogeneous and Strongly Linked to the Squamous Cell Carcinoma Subtype in Esophageal Carcinoma
por: von Loga, Katharina, et al.
Publicado: (2015)

The Expression and Prognostic Value of FGF2, FGFR3, and FGFBP1 in Esophageal Squamous Cell Carcinoma
por: Zhang, Wenjing, et al.
Publicado: (2020)

Targeting MUC1-C reverses the cisplatin resistance of esophageal squamous cell carcinoma in vitro and in vivo
por: Zhao, Yong-Qiang, et al.
Publicado: (2021)

Expression and clinical significance of FGFR1 and FGFR2 in laryngeal squamous cell carcinoma
por: Hu, Mengdie, et al.
Publicado: (2022)

FGFR1 expression defines clinically distinct subtypes in pancreatic cancer
por: Haq, Farhan, et al.
Publicado: (2018)

Downregulation of fibulin‐4 inhibits autophagy and promotes the sensitivity of esophageal squamous cell carcinoma cells to apatinib by activating the Akt‐mTOR signaling pathway
por: Chen, Xiangyu, et al.
Publicado: (2022)

Inhibition of SALL4 reduces tumorigenicity involving epithelial-mesenchymal transition via Wnt/β-catenin pathway in esophageal squamous cell carcinoma
por: He, Jing, et al.
Publicado: (2016)

The Prognostic Significance of FGFR4 Gly388 Polymorphism in Esophageal Squamous Cell Carcinoma after Concurrent Chemoradiotherapy
por: Shim, Hyun-Jeong, et al.
Publicado: (2016)

Fucoidan Does Not Exert Anti-Tumorigenic Effects on Uveal Melanoma Cell Lines
por: Dithmer, Michaela, et al.
Publicado: (2017)

The role of HGF/MET and FGF/FGFR in fibroblast-derived growth stimulation and lapatinib-resistance of esophageal squamous cell carcinoma
por: Saito, Shin, et al.
Publicado: (2015)

The transcription factor LEF1 promotes tumorigenicity and activates the TGF-β signaling pathway in esophageal squamous cell carcinoma
por: Zhao, Yue, et al.
Publicado: (2019)

Dynamic Tumorigenic Trajectory and Transitional Signatures of Oncogenic Evolution by Single-Cell Transcriptomic Profiling of Esophageal Squamous Cell Carcinoma
por: Liu, Hui, et al.
Publicado: (2021)

Identification and characterization of FGFR2(+) hematopoietic stem cell-derived fibrocytes as precursors of cancer-associated fibroblasts induced by esophageal squamous cell carcinoma
por: Qiu, Haibo, et al.
Publicado: (2022)

Overexpressed Gαi1 exerts pro-tumorigenic activity in nasopharyngeal carcinoma
por: Yin, De-Pei, et al.
Publicado: (2023)

Association of fibroblast growth factor receptor 1 gene amplification with poor survival in patients with esophageal squamous cell carcinoma
por: Wang, Dong, et al.
Publicado: (2017)

Melatonin Suppresses Oral Squamous Cell Carcinomas Migration and Invasion through Blocking FGF19/FGFR 4 Signaling Pathway
por: Wang, Leilei, et al.
Publicado: (2021)

Novel targetable FGFR2 and FGFR3 alterations in glioblastoma associate with aggressive phenotype and distinct gene expression programs
por: Georgescu, Maria-Magdalena, et al.
Publicado: (2021)

GATA4 blocks squamous epithelial cell gene expression in human esophageal squamous cells
por: Stavniichuk, Roman, et al.
Publicado: (2021)

Mutational Status of FGFR3 in Oral Squamous Cell Carcinoma
por: Motahhary, P., et al.
Publicado: (2012)

Gene Expression Profiling Reveals Distinct Molecular Subtypes of Esophageal Squamous Cell Carcinoma in Asian Populations()
por: Wang, Fengling, et al.
Publicado: (2019)

Upregulation of sex-determining region Y-box 9 (SOX9) promotes cell proliferation and tumorigenicity in esophageal squamous cell carcinoma
por: Hong, Yingcai, et al.
Publicado: (2015)

KIAA1522 overexpression promotes tumorigenicity and metastasis of esophageal cancer cells through potentiating the ERK activity
por: Xie, Zhi-Hui, et al.
Publicado: (2017)

Development and Validation of the Predictive Model for Esophageal Squamous Cell Carcinoma Differentiation Degree
por: Wang, Yanfeng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9h83a3e9lss6j1pvoh7m19pigr